Establishment Labs Holdings Stock Today
| ESTA Stock | USD 48.95 0.74 1.49% |
Performance10 of 100
| Odds Of DistressLess than 25
|
Establishment Labs is trading at 48.95 as of the 25th of April 2024, a -1.49 percent decrease since the beginning of the trading day. The stock's open price was 49.69. Establishment Labs has about a 25 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat ok performance during the last 90 days. Equity ratings for Establishment Labs Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of May 2022 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 19th of July 2018 | Category Healthcare | Classification Health Care |
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica. The company has 27.46 M outstanding shares of which 4.93 M shares are currently shorted by private and institutional investors with about 10.81 trading days to cover. More on Establishment Labs Holdings
Moving together with Establishment Stock
| 0.68 | NXL | Nexalin Technology | PairCorr |
| 0.68 | RCM | R1 RCM Inc Earnings Call This Week | PairCorr |
Moving against Establishment Stock
| 0.9 | BBLG | Bone Biologics Corp Financial Report 20th of May 2024 | PairCorr |
| 0.81 | UNH | UnitedHealth Group Financial Report 12th of July 2024 | PairCorr |
| 0.8 | HCAT | Health Catalyst Financial Report 14th of May 2024 | PairCorr |
| 0.77 | SINT | SINTX Technologies | PairCorr |
| 0.7 | HSTM | HealthStream | PairCorr |
| 0.65 | NAOV | NanoVibronix | PairCorr |
| 0.64 | NUWE | Nuwellis Financial Report 14th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 13th of May 2024
Establishment Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Establishment Labs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Establishment Labs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Director | Juan Quiros | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Establishment Labs report their recommendations after researching Establishment Labs' financial statements, talking to executives and customers, or listening in on Establishment Labs' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Establishment Labs. The Establishment consensus assessment is calculated by taking the average forecast from all of the analysts covering Establishment Labs. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Establishment Labs' liquidity, profitability, solvency, and operating efficiency, Establishment Labs Holdings is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Establishment Labs is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Establishment Labs' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Establishment Labs' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Establishment Labs' financial leverage. It provides some insight into what part of Establishment Labs' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Establishment Labs Holdings (ESTA) is traded on NASDAQ Exchange in USA. It is located in Building B15 and 25, Alajuela, Costa Rica and employs 908 people. Establishment Labs is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.36 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Establishment Labs's market, we take the total number of its shares issued and multiply it by Establishment Labs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Establishment Labs conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 27.46 M outstanding shares of which 4.93 M shares are currently shorted by private and institutional investors with about 10.81 trading days to cover.
Establishment Labs Holdings currently holds about 65.35 M in cash with (87.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.68.
Check Establishment Labs Probability Of Bankruptcy
Ownership AllocationEstablishment Labs holds a total of 27.46 Million outstanding shares. The majority of Establishment Labs Holdings outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Establishment Labs to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Establishment Labs. Please pay attention to any change in the institutional holdings of Establishment Labs Holdings as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Establishment Ownership Details
Establishment Stock Price Odds Analysis
What are Establishment Labs' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Establishment Labs jumping above the current price in 90 days from now is about 26.52%. The Establishment Labs Holdings probability density function shows the probability of Establishment Labs stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.0881 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Establishment Labs will likely underperform. Additionally, establishment Labs Holdings has an alpha of 0.3687, implying that it can generate a 0.37 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Establishment Labs to move above the current price in 90 days from now is about 26.52 (This Establishment Labs Holdings probability density function shows the probability of Establishment Stock to fall within a particular range of prices over 90 days) .
Establishment Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Establishment Labs that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Establishment Labs' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Establishment Labs' value.| Instituion | Recorded On | Shares | |
| Pura Vida Investments, Llc | 2023-12-31 | 418 K | |
| Kornitzer Capital Management Inc | 2023-12-31 | 389.2 K | |
| Bamco Inc | 2023-12-31 | 334.8 K | |
| Iron Triangle Partners Lp | 2023-12-31 | 331.2 K | |
| Madryn Asset Management, Lp | 2023-09-30 | 321.1 K | |
| Nuveen Asset Management, Llc | 2023-12-31 | 284.3 K | |
| Affinity Asset Advisors, Llc | 2023-12-31 | 228.3 K | |
| Polar Capital Holdings Plc | 2023-12-31 | 226.5 K | |
| Magnetar Financial Llc | 2023-12-31 | 172.1 K | |
| Nantahala Capital Management, Llc | 2023-12-31 | 4.9 M | |
| Jw Asset Management, Llc | 2023-12-31 | 3.2 M |
Establishment Labs Historical Income Statement
Establishment Labs Holdings Income Statement is one of the three primary financial statements used for reporting Establishment's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Establishment Labs revenue and expense. Establishment Labs Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Establishment Labs' Interest Income is projected to decrease significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 3.4 M, whereas Interest Expense is forecasted to decline to about 9.4 M. View More FundamentalsEstablishment Stock Against Markets
Picking the right benchmark for Establishment Labs stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Establishment Labs stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Establishment Labs is critical whether you are bullish or bearish towards Establishment Labs Holdings at a given time. Please also check how Establishment Labs' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Establishment Labs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
Establishment Labs Corporate Directors
Establishment Labs corporate directors refer to members of an Establishment Labs board of directors. The board of directors generally takes responsibility for the Establishment Labs' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Establishment Labs' board members must vote for the resolution. The Establishment Labs board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| David Hung | Independent Director | Profile | |
| Lisa Gersh | Independent Director | Profile | |
| Nicholas Lewin | Independent Director | Profile | |
| Lisa Colleran | Independent Director | Profile |
How to buy Establishment Stock?
Before investing in Establishment Labs, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Establishment Labs. To buy Establishment Labs stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Establishment Labs. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Establishment Labs stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Establishment Labs Holdings stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Establishment Labs Holdings stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Establishment Labs Holdings, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Establishment Stock please use our How to Invest in Establishment Labs guide.
Already Invested in Establishment Labs Holdings?
The danger of trading Establishment Labs Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Establishment Labs is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Establishment Labs. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Establishment Labs is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Establishment Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Establishment Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Establishment Labs Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Establishment Labs Holdings Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Establishment Stock analysis
When running Establishment Labs' price analysis, check to measure Establishment Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Establishment Labs is operating at the current time. Most of Establishment Labs' value examination focuses on studying past and present price action to predict the probability of Establishment Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Establishment Labs' price. Additionally, you may evaluate how the addition of Establishment Labs to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Establishment Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.07) | Revenue Per Share 6.451 | Quarterly Revenue Growth (0.28) | Return On Assets (0.17) | Return On Equity (15.38) |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.